Logo image of APRN

BLUE APRON HOLDINGS INC-A (APRN) Stock Fundamental Analysis

NASDAQ:APRN - Nasdaq - US09523Q3092 - Common Stock - Currency: USD

12.99  -0.01 (-0.08%)

After market: 12.99 0 (0%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to APRN. APRN was compared to 41 industry peers in the Consumer Staples Distribution & Retail industry. Both the profitability and financial health of APRN have multiple concerns. APRN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year APRN has reported negative net income.
APRN had a negative operating cash flow in the past year.
APRN had negative earnings in each of the past 5 years.
In the past 5 years APRN always reported negative operating cash flow.
APRN Yearly Net Income VS EBIT VS OCF VS FCFAPRN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 -50M -100M -150M -200M -250M

1.2 Ratios

APRN has a Return On Assets of -146.26%. This is amonst the worse of the industry: APRN underperforms 90.91% of its industry peers.
Industry RankSector Rank
ROA -146.26%
ROE N/A
ROIC N/A
ROA(3y)-41.24%
ROA(5y)-36.22%
ROE(3y)-169.36%
ROE(5y)-140.05%
ROIC(3y)N/A
ROIC(5y)N/A
APRN Yearly ROA, ROE, ROICAPRN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 -100 -200 -300

1.3 Margins

With an excellent Gross Margin value of 35.18%, APRN belongs to the best of the industry, outperforming 86.36% of the companies in the same industry.
In the last couple of years the Gross Margin of APRN has grown nicely.
APRN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 35.18%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.57%
GM growth 5Y3.16%
APRN Yearly Profit, Operating, Gross MarginsAPRN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 20 -20

More info and screens

0

2. Health

2.1 Basic Checks

APRN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, APRN has about the same amount of shares outstanding.
APRN has a worse debt/assets ratio than last year.
APRN Yearly Shares OutstandingAPRN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 100K 200K 300K 400K
APRN Yearly Total Debt VS Total AssetsAPRN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M 400M 500M

2.2 Solvency

Based on the Altman-Z score of -11.41, we must say that APRN is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -11.41, APRN is doing worse than 93.18% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -11.41
ROIC/WACCN/A
WACC11.65%
APRN Yearly LT Debt VS Equity VS FCFAPRN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 100M -100M 200M -200M

2.3 Liquidity

A Current Ratio of 0.66 indicates that APRN may have some problems paying its short term obligations.
APRN's Current ratio of 0.66 is on the low side compared to the rest of the industry. APRN is outperformed by 88.64% of its industry peers.
A Quick Ratio of 0.63 indicates that APRN may have some problems paying its short term obligations.
APRN has a Quick ratio of 0.63. This is comparable to the rest of the industry: APRN outperforms 50.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.66
Quick Ratio 0.63
APRN Yearly Current Assets VS Current LiabilitesAPRN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M 200M 250M

More info and screens

2

3. Growth

3.1 Past

APRN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.20%.
Looking at the last year, APRN shows a decrease in Revenue. The Revenue has decreased by -4.99% in the last year.
Measured over the past years, APRN shows a very negative growth in Revenue. The Revenue has been decreasing by -12.25% on average per year.
EPS 1Y (TTM)-16.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-27.96%
Revenue 1Y (TTM)-4.99%
Revenue growth 3Y0.26%
Revenue growth 5Y-12.25%
Sales Q2Q%-14.49%

3.2 Future

Based on estimates for the next years, APRN will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.82% on average per year.
The Revenue is expected to grow by 5.20% on average over the next years.
EPS Next Y54.45%
EPS Next 2Y37.61%
EPS Next 3Y26.25%
EPS Next 5Y19.82%
Revenue Next Year-8.95%
Revenue Next 2Y-1.64%
Revenue Next 3Y3.66%
Revenue Next 5Y5.2%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
APRN Yearly Revenue VS EstimatesAPRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
APRN Yearly EPS VS EstimatesAPRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -10 -20 -30 -40 -50

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for APRN. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for APRN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
APRN Price Earnings VS Forward Price EarningsAPRN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
APRN Per share dataAPRN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60

4.3 Compensation for Growth

APRN's earnings are expected to grow with 26.25% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.61%
EPS Next 3Y26.25%

More info and screens

0

5. Dividend

5.1 Amount

APRN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BLUE APRON HOLDINGS INC-A

NASDAQ:APRN (11/10/2023, 8:00:00 PM)

After market: 12.99 0 (0%)

12.99

-0.01 (-0.08%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)11-09 2023-11-09/bmo
Earnings (Next)03-14 2024-03-14/amc
Inst Owners1.56%
Inst Owner Change0%
Ins Owners182.86%
Ins Owner Change0%
Market Cap83.53M
Analysts77.78
Price Target14.62 (12.55%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-83.86%
Min EPS beat(2)-188.07%
Max EPS beat(2)20.34%
EPS beat(4)2
Avg EPS beat(4)-42.67%
Min EPS beat(4)-188.07%
Max EPS beat(4)42.12%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.81%
Min Revenue beat(2)-4.81%
Max Revenue beat(2)-0.8%
Revenue beat(4)1
Avg Revenue beat(4)-1.79%
Min Revenue beat(4)-6.1%
Max Revenue beat(4)4.57%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-38.57%
EPS NQ rev (1m)0%
EPS NQ rev (3m)16.7%
EPS NY rev (1m)0%
EPS NY rev (3m)-59.07%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.8%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.39%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.19
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-27.4
EYN/A
EPS(NY)-3.86
Fwd EYN/A
FCF(TTM)-10.11
FCFYN/A
OCF(TTM)-9.19
OCFYN/A
SpS67.78
BVpS-2.52
TBVpS-2.52
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -146.26%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 35.18%
FCFM N/A
ROA(3y)-41.24%
ROA(5y)-36.22%
ROE(3y)-169.36%
ROE(5y)-140.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.57%
GM growth 5Y3.16%
F-Score4
Asset Turnover5.01
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 32.43%
Cap/Sales 1.35%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.66
Quick Ratio 0.63
Altman-Z -11.41
F-Score4
WACC11.65%
ROIC/WACCN/A
Cap/Depr(3y)25.92%
Cap/Depr(5y)27.6%
Cap/Sales(3y)1.28%
Cap/Sales(5y)1.45%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-27.96%
EPS Next Y54.45%
EPS Next 2Y37.61%
EPS Next 3Y26.25%
EPS Next 5Y19.82%
Revenue 1Y (TTM)-4.99%
Revenue growth 3Y0.26%
Revenue growth 5Y-12.25%
Sales Q2Q%-14.49%
Revenue Next Year-8.95%
Revenue Next 2Y-1.64%
Revenue Next 3Y3.66%
Revenue Next 5Y5.2%
EBIT growth 1Y32.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year76.33%
EBIT Next 3Y27.85%
EBIT Next 5Y21.78%
FCF growth 1Y-154.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-205.9%
OCF growth 3YN/A
OCF growth 5YN/A